SCHEMBL1675232

SCHEMBL1675232

CCNC(=O)c1ccc(-c2ccc3ncnc(NCC(C)(C)C)c3c2)o1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 14/20 0.66
CLK1 P49759 6/20 0.66
CLK2 P49760 6/20 0.66
DYRK1B Q9Y463 6/20 0.66
DYRK1A Q13627 6/20 0.66
CLK3 P49761 1/20 0.52
CYP1A2 P05177 6/20 0.43
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 6/20 0.43
CYP3A4 P08684 6/20 0.43
CYP2D6 P10635 4/20 0.43
USP2 O75604 3/20 0.43
CYP2C19 P33261 3/20 0.43
LMNA P02545 2/20 0.43
CD38 P28907 1/20 0.43
HDAC3 O15379 1/20 0.43
ABL1 P00519 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
INSR P06213 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675210 0.88 CLK4 (0.70) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675287 0.84 CLK4 (0.79) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675128 0.82 CLK4 (0.61) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675111 0.81 CLK4 (0.57) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675219 0.81 CLK4 (0.57) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675235 0.80 CLK4 (0.75) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675356 0.80 CLK4 (0.49) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675100 0.75 CLK4 (0.55) CLK4CLK1CLK2DYRK1BCYP1A2
SCHEMBL1675291 0.74 CLK4 (0.50) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675131 0.71 CLK4 (1.00) CLK4CLK1CLK2DYRK1BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed